New shot aims to slash hepatitis b virus levels
Disease control
Completed
This study tested an experimental injection called RBD1016 in 48 adults with chronic hepatitis B who were already taking standard antiviral pills. The goal was to see if the injection could safely lower hepatitis B surface antigen (HBsAg), a marker of the virus. Participants rece…
Phase: PHASE2 • Sponsor: Suzhou Ribo Life Science Co. Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC